For physicians and health care providers, data presented at the American College of Cardiology Scientific Sessions can change clinical practice and impact the way new therapies are accepted and utilized to improve patient care. For us, new data is providing an opportunity to demonstrate how our therapies are leading to dramatic improvements in the treatment of cardiovascular diseases. Data from these late-breaking trials can help physicians rethink what is possible in managing patients with coronary artery disease and heart failure. Exactly what you’d expect from a global health technology company focused on creating what’s next in innovative cardiovascular care.